Allogeneic refers to cells, tissues, or organs that are derived from a genetically different individual of the same species. This term is commonly used in the context of transplantation, where allogeneic grafts are taken from a donor and transplanted into a recipient. Such procedures often require careful matching and immunosuppressive therapy to prevent rejection by the recipient's immune system. Allogeneic stem cell transplants, for example, are used to treat various blood disorders and cancers.
In a procedure called "allogeneic bone marrow transplant," a donor is found whose marrow matches that of the patient.
Allogeneic means when cells are transplanted they are coming from a donor. It doesn't have to be family related, the donor can be anyone as long as it matches. Some studies have shown it can come from an actual umbilical chord.
something in your mothers a#@ lmfao(:
An "allogenic" transplant is a human-to-human transplant. (A "xenogenic" transplant would be animal-to-human).
James L. Biesecker has written: 'Cellular and humoral immunity after allogeneic transplantation in the rat'
The term for bone marrow from a close relative is "allogeneic bone marrow transplant."
The term that refers to originating within another is allogeneic. It is a medical term that is used in transplantation biology.
12-15 lakh for an allogeneic transplant and 8-10 lakh for an autologous transplant approximately
A blood transfusion in which the blood comes from another person is called an allogeneic transfusion. This type of transfusion typically uses donated blood that has been screened and matched to the recipient's blood type to ensure compatibility and minimize the risk of adverse reactions. Allogeneic transfusions are commonly used in various medical situations, such as surgeries, trauma care, or treating certain medical conditions.
The FDA has issued a draft Guidance recommending all allogeneic, and selected autologous, blood donations be screened for T. cruzi.
FDA guidelines require allogeneic blood donors to have a hemoglobin level or 12.5 g/dL or greater, or a hematocrit of 38% or greater. Autologous donors (self-donation) must have a hematocrit of at least 33%.
Torsten Mattsson has written: 'Oral side effects of allogeneic bone marrow transplantation' -- subject(s): Adverse effects, Bone Marrow Transplantation, Homologous Transplantation, Mouth Mucosa, Oral Manifestations